These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24146184)

  • 21. [Role of enzymatic cross-links and non-enzymatic cross-link, advanced glycation end products, as a determinant of bone quality in osteoporosis and diabetes].
    Saito M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():209-13. PubMed ID: 18161108
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus.
    Yoon MS; Jankowski V; Montag S; Zidek W; Henning L; Schlüter H; Tepel M; Jankowski J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):377-81. PubMed ID: 15369762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameters for measurement of oxidative stress in diabetes mellitus: applicability of enzyme-linked immunosorbent assay for clinical evaluation.
    Noiri E; Tsukahara H
    J Investig Med; 2005 May; 53(4):167-75. PubMed ID: 15974243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New markers of advanced damage caused by oxidative and carbonyl stress].
    Kalousová M; Zima T; Tesar V; Stípek S
    Sb Lek; 2001; 102(4):465-72. PubMed ID: 12448197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylglyoxal: possible link between hyperglycaemia and immune suppression?
    Price CL; Knight SC
    Trends Endocrinol Metab; 2009 Sep; 20(7):312-7. PubMed ID: 19709901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycation, receptor-mediated cell activation and vascular complications of diabetes.
    Thornalley PJ
    Diab Vasc Dis Res; 2004 May; 1(1):21-2. PubMed ID: 16305051
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Moringa oleifera on advanced glycation end-product formation and lipid metabolism gene expression in HepG2 cells.
    Sangkitikomol W; Rocejanasaroj A; Tencomnao T
    Genet Mol Res; 2014 Jan; 13(1):723-35. PubMed ID: 24615037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [AGE-RAGE system].
    Harashima A; Munesue S; Yamamoto Y
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():49-52. PubMed ID: 27266061
    [No Abstract]   [Full Text] [Related]  

  • 31. [Atherosclerosis, alcohol and diabetes].
    Bartos V
    Vnitr Lek; 2002 Jun; 48(6):529-33. PubMed ID: 12132355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycation and biomarkers of vascular complications of diabetes.
    Beisswenger PJ
    Amino Acids; 2012 Apr; 42(4):1171-83. PubMed ID: 21042818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease.
    Takeuchi M; Yamagishi S
    J Alzheimers Dis; 2009; 16(4):845-58. PubMed ID: 19387117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oxidative stress and diabetes: role in the development of chronic complications].
    Lapolla A; Fedele D
    Minerva Endocrinol; 1993 Sep; 18(3):99-108. PubMed ID: 8183182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonyl stress and diabetic complications.
    Miyata T; Ishikawa N; van Ypersele de Strihou C
    Clin Chem Lab Med; 2003 Sep; 41(9):1150-8. PubMed ID: 14598864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.
    Ceriello A
    Diabetes Nutr Metab; 1999 Feb; 12(1):42-6. PubMed ID: 10517306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycotoxins in the diet promote diabetes and diabetic complications.
    Vlassara H; Striker G
    Curr Diab Rep; 2007 Jun; 7(3):235-41. PubMed ID: 17547841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical modification of proteins by lipids in diabetes.
    Baynes JW
    Clin Chem Lab Med; 2003 Sep; 41(9):1159-65. PubMed ID: 14598865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Maillard reaction. From nutritional problems to preventive medicine.
    Robert L; Labat-Robert J; Robert AM
    Pathol Biol (Paris); 2010 Jun; 58(3):200-6. PubMed ID: 19896300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.